Journal
JNP-JOURNAL FOR NURSE PRACTITIONERS
Volume 15, Issue 5, Pages 323-327Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.nurpra.2019.01.005
Keywords
buprenorphine; drug treatment; medically assisted treatment; opioid use disorder
Categories
Ask authors/readers for more resources
A tremendous treatment gap exists for the care of persons with opioid use disorder. The vast majority of waivered practitioners, more than 90%, are in urban United States counties. The Comprehensive Addiction and Recovery Act of July 2016 enabled nurse practitioners to help fill that gap by prescribing buprenorphine for opioid use disorder. Free training is available for nurse practitioners who can play a key part in stemming the opioid epidemic in the US by obtaining a Drug Enforcement Administration waiver to prescribe buprenorphine, which is a mainstay treatment for opioid addiction. (C) 2019 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
